SG Americas Securities’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-150,876
| Closed | -$2.32M | – | 3361 |
|
|
2025
Q4 | $2.32M | Buy |
150,876
+134,122
| +801% | +$1.48M | ﹤0.01% | 1440 |
|
|
2025
Q3 | $166K | Buy |
16,754
+3,894
| +30% | +$40.5K | ﹤0.01% | 2847 |
|
|
2025
Q2 | $128K | Sell |
12,860
-39,114
| -75% | -$412K | ﹤0.01% | 2523 |
|
|
2025
Q1 | $674K | Sell |
51,974
-25,550
| -33% | -$338K | ﹤0.01% | 1528 |
|
|
2024
Q4 | $990K | Buy |
+77,524
| New | +$938K | ﹤0.01% | 870 |
|
|
2024
Q2 | – | Sell |
-12,720
| Closed | -$158K | – | 2958 |
|
|
2024
Q1 | $158K | Sell |
12,720
-17,973
| -59% | -$234K | ﹤0.01% | 2158 |
|
|
2023
Q4 | $429K | Sell |
30,693
-44,615
| -59% | -$620K | ﹤0.01% | 1578 |
|
|
2023
Q3 | $1.11M | Buy |
+75,308
| New | +$1.06M | 0.01% | 1181 |
|
|
2023
Q2 | – | Sell |
-72,403
| Closed | -$710K | – | 2502 |
|
|
2023
Q1 | $710K | Buy |
+72,403
| New | +$773K | 0.01% | 1433 |
|
|
2022
Q4 | – | Sell |
-23,823
| Closed | -$249K | – | 3131 |
|
|
2022
Q3 | $249K | Sell |
23,823
-3,906
| -14% | -$50.9K | ﹤0.01% | 2137 |
|
|
2022
Q2 | $349K | Buy |
+27,729
| New | +$295K | ﹤0.01% | 2270 |
|
|
2022
Q1 | – | Sell |
-33,402
| Closed | -$470K | – | 3077 |
|
|
2021
Q4 | $470K | Sell |
33,402
-12,223
| -27% | -$201K | ﹤0.01% | 2204 |
|
|
2021
Q3 | $876K | Buy |
+45,625
| New | +$606K | ﹤0.01% | 2022 |
|
|
2021
Q2 | – | Sell |
-20,481
| Closed | -$201K | – | 2933 |
|
|
2021
Q1 | $201K | Buy |
20,481
+8,551
| +72% | +$70.5K | ﹤0.01% | 2678 |
|
|
2020
Q4 | $53K | Sell |
11,930
-132,370
| -92% | -$599K | ﹤0.01% | 3136 |
|
|
2020
Q3 | $623K | Buy |
+144,300
| New | +$1.03M | ﹤0.01% | 1492 |
|
|
2020
Q2 | – | Sell |
-16,907
| Closed | -$60K | – | 3724 |
|
|
2020
Q1 | $60K | Buy |
+16,907
| New | +$78.4K | ﹤0.01% | 3143 |
|
|
2018
Q3 | – | Sell |
-9,036
| Closed | -$138K | – | 3216 |
|
|
2018
Q2 | $138K | Buy |
9,036
+3,310
| +58% | +$57.2K | ﹤0.01% | 2865 |
|
|
2018
Q1 | $114K | Sell |
5,726
-2,891
| -34% | -$49.9K | ﹤0.01% | 2847 |
|
|
2017
Q4 | $161K | Sell |
8,617
-4,717
| -35% | -$94.7K | ﹤0.01% | 2587 |
|
|
2017
Q3 | $287K | Buy |
+13,334
| New | +$211K | ﹤0.01% | 2275 |
|
|
2016
Q4 | – | Sell |
-11,904
| Closed | -$125K | – | 3185 |
|
|
2016
Q3 | $125K | Buy |
+11,904
| New | +$171K | ﹤0.01% | 2879 |
|
|
2015
Q4 | – | Sell |
-4,215
| Closed | -$103K | – | 2755 |
|
|
2015
Q3 | $103K | Buy |
+4,215
| New | +$119K | ﹤0.01% | 1864 |
|
|
2015
Q2 | – | Sell |
-6,540
| Closed | -$147K | – | 2649 |
|
|
2015
Q1 | $147K | Buy |
+6,540
| New | +$125K | ﹤0.01% | 2060 |
|
|
2014
Q4 | – | Sell |
-6,072
| Closed | -$87K | – | 3190 |
|
|
2014
Q3 | $87K | Buy |
+6,072
| New | +$87.5K | ﹤0.01% | 2405 |
|
|
2014
Q1 | – | Sell |
-3,223
| Closed | -$63K | – | 2486 |
|
|
2013
Q4 | $63K | Sell |
3,223
-44
| -1% | -$644 | ﹤0.01% | 2446 |
|
|
2013
Q3 | $39K | Sell |
3,267
-8,995
| -73% | -$113K | ﹤0.01% | 2826 |
|
|
2013
Q2 | $135K | Buy |
+12,262
| New | +$258K | ﹤0.01% | 1940 |
|
Other funds holding DVAX
SG Americas Securities's DVAX Position: Q1 2026 in Review
SG Americas Securities sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 150,876 shares — an estimated $2.32M sold.
SG Americas Securities first reported a position in DVAX in Q2 2013 and held it in 28 quarters. The position peaked at $2.32M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- SG Americas Securities reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- SG Americas Securities sold 150,876 Dynavax Technologies shares in Q1 2026, an estimated $2.32M.
- SG Americas Securities first reported a position in Dynavax Technologies in Q2 2013 and held it in 28 quarters.
- SG Americas Securities's Dynavax Technologies position peaked at $2.32M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.